Autonomy Department; ARS Île-de-France
Paris, ARS Île-de-France, 75019, France
NCT Number: NCT04677283
The main purpose is to study the prevalence of Covid-19 in EHPAD. The primary endpoint will be the combination of PCR results and symptomatology, making it possible to define positive cases in EHPAD, in residents and professionals in contact with them. The prevalence obtained can be compared with the results of serology if these are performed.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, ARS Île-de-France, 75019, France
This study is taking place in several nursing homes in Ile-de-France, which will be recruited at the end of the diagnostic campaign.
At the initiative of the ARS Ile-de-France, residents and professionals of selected EHPADs will be subjected to systematic screening by RT-PCR for Covid-19, then by serology after the first screening, regardless of whether either the result
Samples, by nasopharyngeal swab for RT-PCR, by capillary blood sampling or venipuncture according to the technique for serology, will be carried out according to the doctrines issued by the ARS Ile de France and the variations proposed by the appropriate departmental directorates in depending on local resources. The results will be brought to the attention of EHPADs to adapt the care of residents and positive professionals.
Data will be collected daily from collection for the first test (RT-PCR), or retrospectively if the collection took place before the study.
Regarding the approach for collecting serologies:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 Months
Time frame: 3 Months
Time frame: 3 Months
Time frame: 3 Months
Time frame: 3 Months
Time frame: 3 Months
Gérond'if
Other
Acronym: COVID - EHPAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04763681
COVID-19, Coronaviridae Infections
Toronto, Ontario, Canada
View Trial DetailsNCT04747249
COVID-19, Coronaviridae Infections
Caen, France
View Trial DetailsNCT06305793
COVID-19, Chronic Disease
Durham, North Carolina, United States
View Trial DetailsNCT04794829
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial Details